ABOLERIS PHARMA
ABOLERIS PHARMA is a Healthcare & Life Sciences startup based in France, most recent round Series A, 1 tracked investor.
About ABOLERIS PHARMA
ABOLERIS PHARMA is a company founded in 2018 headquartered in France. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
AbolerIS Pharma develops potentially best-in-class and first-in-class, curative-intent therapies designed to restore immune tolerance by inducing an immune system reset. The company is advancing a novel class of antibodies that target CD45RC, a key marker on pathogenic Effector T and B cells, to restore immune tolerance by selectively depleting the Effector cells while preserving Regulatory cells and overall immune memory.
Explore ABOLERIS PHARMA's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.